Literature DB >> 35308712

Blood Ordering and Transfusion Practices: An Insight Toward Better Utility of Blood Products.

Samra Waheed1, Munira Borhany1, Madiha Abid1, Imran Naseer1, Tahir Shamsi1.   

Abstract

Background An adequate supply of quality blood products is the backbone of any hospital. To maintain it, the utilization and wastage of the products should be closely monitored. Objective To determine the crossmatch to transfusion (C/T) ratio, transfusion probability (%T), and transfusion index (Ti) of packed red blood cells and to review the use of platelets. Materials and methods A total of 6,326 hematological patients receiving packed red blood cells were included in the study. The random donor platelets that were prepared during this period were also included to know the actual utilization of platelets. Results A total of 26,146 crossmatches were requested for these 6,326 patients in three years. Out of these, 26,024 units were issued and transfused to the patients. The CT ratio of our data was calculated to be 1.00, the transfusion probability was found to be 98.1%, and the transfusion index was computed to be 0.99. For random donor platelets, 37,162 were prepared from whole blood during this period, while 30,971 platelets were transfused to the patients. Conclusion The overall results of our analysis showed proper utilization of blood products at our institution. The wastage was considered to be minimal.
Copyright © 2022, Waheed et al.

Entities:  

Keywords:  blood transfusion; crossmatch; random donor platelets; transfusion index; transfusion probability; transfusion ratio

Year:  2022        PMID: 35308712      PMCID: PMC8920822          DOI: 10.7759/cureus.22075

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  11 in total

1.  Blood utilisation in elective general surgery cases: requirements, ordering and transfusion practices.

Authors:  M Vibhute; S K Kamath; A Shetty
Journal:  J Postgrad Med       Date:  2000 Jan-Mar       Impact factor: 1.476

2.  An audit of blood cross-match ordering practices at the Aga Khan University Hospital: first step towards a Maximum Surgical Blood Ordering Schedule.

Authors:  T Chawla; G N Kakepoto; M A Khan
Journal:  J Pak Med Assoc       Date:  2001-07       Impact factor: 0.781

3.  An analysis of blood utilization for elective surgery in a tertiary medical centre in Malaysia.

Authors:  S Jayaranee; R Prathiba; N Vasanthi; C G Lopez
Journal:  Malays J Pathol       Date:  2002-06       Impact factor: 0.656

4.  The maximum surgical blood order schedule and surgical blood use in the United States.

Authors:  B A Friedman; H A Oberman; A R Chadwick; K I Kingdon
Journal:  Transfusion       Date:  1976 Jul-Aug       Impact factor: 3.157

5.  Strategies for the review of transfusion practices.

Authors:  L E Silberstein; M S Kruskall; L C Stehling; M F Johnston; R C Rutman; C T Samia; G Ramsey; R S Eisenstaedt
Journal:  JAMA       Date:  1989-10-13       Impact factor: 56.272

6.  Successful implementation of Maximum Surgical Blood Order Schedule.

Authors:  T A Lowery; J A Clark
Journal:  J Med Assoc Ga       Date:  1989-03

7.  Hemotherapy in elective surgery: an incidence report, review of the literature, and alternatives for guideline appraisal.

Authors:  J H Mead; C D Anthony; M Sattler
Journal:  Am J Clin Pathol       Date:  1980-08       Impact factor: 2.493

8.  Utilization management in the blood transfusion service.

Authors:  Jeremy Ryan Andrew Peña; Walter Sunny Dzik
Journal:  Clin Chim Acta       Date:  2013-09-29       Impact factor: 3.786

9.  Conserving blood in preparation for elective surgery.

Authors:  A Baraka; T Juma; S K Asfar; H al-Sayer
Journal:  J R Soc Med       Date:  1991-10       Impact factor: 18.000

10.  Blood Transfusion Practice before and after Implementation of Type and Screen Protocol in Emergency Department of a University Affiliated Hospital in Iran.

Authors:  Mostafa Alavi-Moghaddam; Mahmoud Bardeh; Hossein Alimohammadi; Habib Emami; Seyed-Mostafa Hosseini-Zijoud
Journal:  Emerg Med Int       Date:  2014-09-02       Impact factor: 1.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.